Management of atrial fibrillation after cardiac surgery - Part II

Prevention and treatment

Laureen L. Hill, Charl De Wet, Charles W. Hogue

Research output: Contribution to journalArticle

Abstract

In light of the relationship between postoperative AF and adverse patient outcomes, there is tremendous interest in pharmacologic and nonpharmacologic prophylactic therapy. Presently, β-adrenergic receptor blocking drugs are the only drugs that have been shown to consistently reduce the frequency of postoperative AF, and their use should be considered early after surgery, particularly for patients receiving these treatments preoperatively. Although data suggest that sotalol and amiodarone may be effective for prophylaxis, conflicting data have been reported, and questions remain as to the differential benefit of this therapy compared with β-blockers. Perioperative drug trials have not been adequately powered to ensure the safety of this therapy for routine, noninvestigational use. Preliminary studies of atrial pacing therapy for the prevention of AF after cardiac surgery are encouraging, but the most effective type and mode of pacing have not yet been determined. The treatment goals of postoperative AF are similar to those for nonsurgical settings. In the absence of hemodynamic instability, in which case electrical cardioversion is indicated immediately, therapy is aimed at controlling ventricular rate and pharmacologic cardioversion. Pharmacologic therapy should be based on the patient's susceptibility to proarrhythmic side effects. Anticoagulation should be considered for postoperative AF, but the individual susceptibility for hemorrhagic complications must be carefully considered.

Original languageEnglish (US)
Pages (from-to)626-637
Number of pages12
JournalJournal of Cardiothoracic and Vascular Anesthesia
Volume16
Issue number5
DOIs
StatePublished - Oct 2002
Externally publishedYes

Fingerprint

Atrial Fibrillation
Thoracic Surgery
Electric Countershock
Therapeutics
Pharmaceutical Preparations
Sotalol
Amiodarone
Adrenergic Receptors
Hemodynamics
Safety

Keywords

  • Atrial fibrillation
  • Cardiac surgery
  • Postoperative complications
  • Prevention and treatment

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Management of atrial fibrillation after cardiac surgery - Part II : Prevention and treatment. / Hill, Laureen L.; De Wet, Charl; Hogue, Charles W.

In: Journal of Cardiothoracic and Vascular Anesthesia, Vol. 16, No. 5, 10.2002, p. 626-637.

Research output: Contribution to journalArticle

Hill, Laureen L. ; De Wet, Charl ; Hogue, Charles W. / Management of atrial fibrillation after cardiac surgery - Part II : Prevention and treatment. In: Journal of Cardiothoracic and Vascular Anesthesia. 2002 ; Vol. 16, No. 5. pp. 626-637.
@article{12f511b554524c86a66d59ce62252582,
title = "Management of atrial fibrillation after cardiac surgery - Part II: Prevention and treatment",
abstract = "In light of the relationship between postoperative AF and adverse patient outcomes, there is tremendous interest in pharmacologic and nonpharmacologic prophylactic therapy. Presently, β-adrenergic receptor blocking drugs are the only drugs that have been shown to consistently reduce the frequency of postoperative AF, and their use should be considered early after surgery, particularly for patients receiving these treatments preoperatively. Although data suggest that sotalol and amiodarone may be effective for prophylaxis, conflicting data have been reported, and questions remain as to the differential benefit of this therapy compared with β-blockers. Perioperative drug trials have not been adequately powered to ensure the safety of this therapy for routine, noninvestigational use. Preliminary studies of atrial pacing therapy for the prevention of AF after cardiac surgery are encouraging, but the most effective type and mode of pacing have not yet been determined. The treatment goals of postoperative AF are similar to those for nonsurgical settings. In the absence of hemodynamic instability, in which case electrical cardioversion is indicated immediately, therapy is aimed at controlling ventricular rate and pharmacologic cardioversion. Pharmacologic therapy should be based on the patient's susceptibility to proarrhythmic side effects. Anticoagulation should be considered for postoperative AF, but the individual susceptibility for hemorrhagic complications must be carefully considered.",
keywords = "Atrial fibrillation, Cardiac surgery, Postoperative complications, Prevention and treatment",
author = "Hill, {Laureen L.} and {De Wet}, Charl and Hogue, {Charles W.}",
year = "2002",
month = "10",
doi = "10.1053/jcan.2002.126931",
language = "English (US)",
volume = "16",
pages = "626--637",
journal = "Journal of Cardiothoracic and Vascular Anesthesia",
issn = "1053-0770",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Management of atrial fibrillation after cardiac surgery - Part II

T2 - Prevention and treatment

AU - Hill, Laureen L.

AU - De Wet, Charl

AU - Hogue, Charles W.

PY - 2002/10

Y1 - 2002/10

N2 - In light of the relationship between postoperative AF and adverse patient outcomes, there is tremendous interest in pharmacologic and nonpharmacologic prophylactic therapy. Presently, β-adrenergic receptor blocking drugs are the only drugs that have been shown to consistently reduce the frequency of postoperative AF, and their use should be considered early after surgery, particularly for patients receiving these treatments preoperatively. Although data suggest that sotalol and amiodarone may be effective for prophylaxis, conflicting data have been reported, and questions remain as to the differential benefit of this therapy compared with β-blockers. Perioperative drug trials have not been adequately powered to ensure the safety of this therapy for routine, noninvestigational use. Preliminary studies of atrial pacing therapy for the prevention of AF after cardiac surgery are encouraging, but the most effective type and mode of pacing have not yet been determined. The treatment goals of postoperative AF are similar to those for nonsurgical settings. In the absence of hemodynamic instability, in which case electrical cardioversion is indicated immediately, therapy is aimed at controlling ventricular rate and pharmacologic cardioversion. Pharmacologic therapy should be based on the patient's susceptibility to proarrhythmic side effects. Anticoagulation should be considered for postoperative AF, but the individual susceptibility for hemorrhagic complications must be carefully considered.

AB - In light of the relationship between postoperative AF and adverse patient outcomes, there is tremendous interest in pharmacologic and nonpharmacologic prophylactic therapy. Presently, β-adrenergic receptor blocking drugs are the only drugs that have been shown to consistently reduce the frequency of postoperative AF, and their use should be considered early after surgery, particularly for patients receiving these treatments preoperatively. Although data suggest that sotalol and amiodarone may be effective for prophylaxis, conflicting data have been reported, and questions remain as to the differential benefit of this therapy compared with β-blockers. Perioperative drug trials have not been adequately powered to ensure the safety of this therapy for routine, noninvestigational use. Preliminary studies of atrial pacing therapy for the prevention of AF after cardiac surgery are encouraging, but the most effective type and mode of pacing have not yet been determined. The treatment goals of postoperative AF are similar to those for nonsurgical settings. In the absence of hemodynamic instability, in which case electrical cardioversion is indicated immediately, therapy is aimed at controlling ventricular rate and pharmacologic cardioversion. Pharmacologic therapy should be based on the patient's susceptibility to proarrhythmic side effects. Anticoagulation should be considered for postoperative AF, but the individual susceptibility for hemorrhagic complications must be carefully considered.

KW - Atrial fibrillation

KW - Cardiac surgery

KW - Postoperative complications

KW - Prevention and treatment

UR - http://www.scopus.com/inward/record.url?scp=0036793167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036793167&partnerID=8YFLogxK

U2 - 10.1053/jcan.2002.126931

DO - 10.1053/jcan.2002.126931

M3 - Article

VL - 16

SP - 626

EP - 637

JO - Journal of Cardiothoracic and Vascular Anesthesia

JF - Journal of Cardiothoracic and Vascular Anesthesia

SN - 1053-0770

IS - 5

ER -